Heart valve patients may go home sooner: new study reveals key factors
NCT ID NCT02956915
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracked 300 patients with severe aortic stenosis who had a minimally invasive heart valve replacement (TAVI) to see how long they stayed in the hospital and why some stayed longer than 3 days. The goal was to find out what factors, like needing a blood transfusion or a pacemaker, lead to longer hospital stays. The results could help doctors plan earlier discharge for suitable patients, saving costs and reducing hospital time for elderly and frail individuals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE SYMPTOMATIC AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Bichat - Claude Bernard Hospital
Paris, France
-
Brest University Hospital
Brest, France
-
Jacques Cartier Private Hospital
Massy, France
-
Rennes University Hospital
Rennes, France
-
Rouen University Hospital
Rouen, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.